Ticker Details
GoodRx Holdings, Inc.
IPO Date:	September 23, 2020
Sector:	Healthcare
Industry:	Health Information Services
Market Cap:	$1.19B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 3.15%
Avg Daily Range (30 D):	$0.11 | 3.11%
Avg Daily Range (90 D):	$0.09 | 2.85%

Institutional Daily Volume
Avg Daily Volume:	1.91M
Avg Daily Volume (30 D):	1.53M
Avg Daily Volume (90 D):	1.39M

Trade Size
Avg Trade Size (Sh.):	126
Avg Trade Size (Sh.) (30 D):	143
Avg Trade Size (Sh.) (90 D):	145

Institutional Trades
Total Institutional Trades:	2,678
Avg Institutional Trade:	$1.83M
Avg Institutional Trade (30 D):	$1.01M
Avg Institutional Trade (90 D):	$1.1M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$2.22M
Avg Closing Trade (30 D):	$.78M
Avg Closing Trade (90 D):	$1.15M
Avg Closing Volume:	130.15K

News

May 10, 2026 @ 12:24 PM GoodRx vs. Hims & Hers Health: Stagnation vs. Grow... Source: Cory Renauer

Apr 15, 2026 @ 5:25 PM GoodRx Rallies As Wegovy HD Rollout Targets Self-P... Source: Vandana Singh

Feb 6, 2026 @ 1:15 AM Amazon Is Now Offering Novo Nordisk's Wegovy Pill ... Source: Reuben Gregg Brewer

Jan 5, 2026 @ 5:23 PM Novo Nordisk's Wegovy Weight Loss Pill Hits US Pha... Source: Vandana Singh

Nov 17, 2025 @ 6:01 PM Novo Nordisk Leans Into Affordability Amid Rising ... Source: Vandana Singh

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.05	$.03	$
Diluted EPS	$.05	$.02	$
Revenue	$785.23M	$200.41M	$194.01M
Gross Profit
Net Income / Loss	$16.25M	$8.54M	$1.17M
Operating Income / Loss	$74.94M	$23.63M	$14.01M
Cost of Revenue
Net Cash Flow	$14.8M	$60.4M	$-26.11M
PE Ratio